82 reports of this reaction
2.6% of all SODIUM POLYSTYRENE SULFONATE reports
#7 most reported adverse reaction
DEATH is the #7 most commonly reported adverse reaction for SODIUM POLYSTYRENE SULFONATE, manufactured by ANI Pharmaceuticals, Inc.. There are 82 FDA adverse event reports linking SODIUM POLYSTYRENE SULFONATE to DEATH. This represents approximately 2.6% of all 3,148 adverse event reports for this drug.
Patients taking SODIUM POLYSTYRENE SULFONATE who experience death should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DEATH is a less commonly reported adverse event for SODIUM POLYSTYRENE SULFONATE, but still significant enough to appear in the safety profile.
In addition to death, the following adverse reactions have been reported for SODIUM POLYSTYRENE SULFONATE:
The following drugs have also been linked to death in FDA adverse event reports:
DEATH has been reported as an adverse event in 82 FDA reports for SODIUM POLYSTYRENE SULFONATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DEATH accounts for approximately 2.6% of all adverse event reports for SODIUM POLYSTYRENE SULFONATE, making it a notable side effect.
If you experience death while taking SODIUM POLYSTYRENE SULFONATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.